Abstract

ObjectivesUntil recently, the European Committee on Antimicrobial Susceptibility Testing (EUCAST) recommended the cefoxitin disc to screen for mecA-mediated β-lactam resistance in Staphylococcus pseudintermedius. A recent study indicated that cefoxitin was inferior to oxacillin in this respect. We have re-evaluated cefoxitin and oxacillin discs for screening for methicillin resistance in S. pseudintermedius. MethodsWe included 224 animal and human S. pseudintermedius isolates from Europe (n = 108) and North America (n = 116), of which 109 were mecA-positive. Disc diffusion was performed per EUCAST recommendations using 30-μg cefoxitin and 1-μg oxacillin discs from three manufacturers and Mueller–Hinton agar from two manufacturers. ResultsCefoxitin inhibition zones ranged from 6 to 33 mm for mecA-positive S. pseudintermedius (MRSP) and from 29 to 41 mm for mecA-negative S. pseudintermedius (MSSP). The corresponding oxacillin zone intervals were 6–20 mm and 19–30 mm. For cefoxitin 16% (95% CI 14.8–18.0%) of the isolates were in the area where positive and negative results overlapped. For oxacillin the corresponding number was 2% (1.6–2.9%). For oxacillin a breakpoint of susceptible (S) ≥ 20 mm and resistant (R) <20 mm resulted in only 0.4% and 1.1% very major error and major error rates respectively. ConclusionsThis investigation confirms that the 1-μg oxacillin disc predicts mecA-mediated methicillin resistance in S. pseudintermedius better than the 30-μg cefoxitin disc. For a 1-μg oxacillin disc we propose that 20 mm should be used as cut off for resistance, i.e. isolates with a zone diameter <20 mm are resistant to all β-lactam antibiotics except those with activity against methicillin-resistant staphylococci.

Highlights

  • Staphylococcus pseudintermedius is a coagulase-positive Staphylococcus species adapted to Canidae and one of the most important bacterial pathogens in dogs, but it causes infections in humans including serious infections [1e4]

  • Some Methicillin (b-lactam)-resistant S. pseudintermedius (MRSP) clones such as sequence type (ST) 71 display resistance to virtually all antimicrobial agents licensed for veterinary use, posing one of the most challenging problems so far encountered in the antimicrobial management of veterinary infectious diseases

  • According to a recent review, approximately two-thirds of MRSP isolates submitted to the multilocus sequence typing (MLST) database originate from skin samples associated with pyoderma, surgical site and wound infections [1]

Read more

Summary

Introduction

Staphylococcus pseudintermedius is a coagulase-positive Staphylococcus species adapted to Canidae and one of the most important bacterial pathogens in dogs, but it causes infections in humans including serious infections [1e4]. The introduction of matrixassisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) for bacterial identification has shown that the incidence of S. pseudintermedius infections in humans is probably underestimated due to mis-identification as Staphylococcus aureus [4e6]. Hitherto, according to our knowledge, only mecA-based resistance have been reported in S. pseudintermedius. Variable MRSP prevalence among clinical isolates (1e33%) has been reported by recent studies from different geographical areas and study populations [2,10e15]. A study in the United States (US) showed that the prevalence of methicillin resistance in canine clinical isolates increased from

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call